Cargando…
Psychiatric comorbidity in clinically stable COVID-19 patients
AIMS: To identify prevalence of psychiatric comorbidity in clinically stable COVID-19 patients. MATERIALS AND METHODS: A cross-sectional single point observational study was conducted among clinically stable 72 COVID-19 infected patients. Psychiatric comorbidity was assessed with the help of DSM-5 S...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992745/ https://www.ncbi.nlm.nih.gov/pubmed/35400739 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_312_21 |
_version_ | 1784683790819393536 |
---|---|
author | Gaur, Vikas Salvi, Deepak Gautam, Manaswi Sangwan, Vaundhra Tambi, Tanushi Kalia, Anchin Singh, Nishant |
author_facet | Gaur, Vikas Salvi, Deepak Gautam, Manaswi Sangwan, Vaundhra Tambi, Tanushi Kalia, Anchin Singh, Nishant |
author_sort | Gaur, Vikas |
collection | PubMed |
description | AIMS: To identify prevalence of psychiatric comorbidity in clinically stable COVID-19 patients. MATERIALS AND METHODS: A cross-sectional single point observational study was conducted among clinically stable 72 COVID-19 infected patients. Psychiatric comorbidity was assessed with the help of DSM-5 Self-Rated Level 1 CCSM—Adult scale. RESULTS: The prevalence of psychiatric comorbidity was 76.4% (n = 55). Depression was the most common diagnosis in 44.44% (n = 32) followed by anxiety (34.72%, n = 25), somatic symptoms (26.39%, n = 19), sleep problems (23.61%, n = 17). Around 45 .83 % (n = 33) patients considered COVID-19 infection as potentially life-threatening and 23.62% (n=17) patients experienced discrimination and stigma after being diagnosed with COVID-19 infection. Using binary logistic regression, physical symptoms was identified as a risk factor for psychiatric comorbidity. CONCLUSION: Our study provides evidence of a significant impact of COVID-19 infection on mental health in COVID-19 patients. |
format | Online Article Text |
id | pubmed-8992745 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-89927452022-04-09 Psychiatric comorbidity in clinically stable COVID-19 patients Gaur, Vikas Salvi, Deepak Gautam, Manaswi Sangwan, Vaundhra Tambi, Tanushi Kalia, Anchin Singh, Nishant Indian J Psychiatry Brief Communication AIMS: To identify prevalence of psychiatric comorbidity in clinically stable COVID-19 patients. MATERIALS AND METHODS: A cross-sectional single point observational study was conducted among clinically stable 72 COVID-19 infected patients. Psychiatric comorbidity was assessed with the help of DSM-5 Self-Rated Level 1 CCSM—Adult scale. RESULTS: The prevalence of psychiatric comorbidity was 76.4% (n = 55). Depression was the most common diagnosis in 44.44% (n = 32) followed by anxiety (34.72%, n = 25), somatic symptoms (26.39%, n = 19), sleep problems (23.61%, n = 17). Around 45 .83 % (n = 33) patients considered COVID-19 infection as potentially life-threatening and 23.62% (n=17) patients experienced discrimination and stigma after being diagnosed with COVID-19 infection. Using binary logistic regression, physical symptoms was identified as a risk factor for psychiatric comorbidity. CONCLUSION: Our study provides evidence of a significant impact of COVID-19 infection on mental health in COVID-19 patients. Wolters Kluwer - Medknow 2022 2022-01-21 /pmc/articles/PMC8992745/ /pubmed/35400739 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_312_21 Text en Copyright: © 2022 Indian Journal of Psychiatry https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 4.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Brief Communication Gaur, Vikas Salvi, Deepak Gautam, Manaswi Sangwan, Vaundhra Tambi, Tanushi Kalia, Anchin Singh, Nishant Psychiatric comorbidity in clinically stable COVID-19 patients |
title | Psychiatric comorbidity in clinically stable COVID-19 patients |
title_full | Psychiatric comorbidity in clinically stable COVID-19 patients |
title_fullStr | Psychiatric comorbidity in clinically stable COVID-19 patients |
title_full_unstemmed | Psychiatric comorbidity in clinically stable COVID-19 patients |
title_short | Psychiatric comorbidity in clinically stable COVID-19 patients |
title_sort | psychiatric comorbidity in clinically stable covid-19 patients |
topic | Brief Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992745/ https://www.ncbi.nlm.nih.gov/pubmed/35400739 http://dx.doi.org/10.4103/indianjpsychiatry.indianjpsychiatry_312_21 |
work_keys_str_mv | AT gaurvikas psychiatriccomorbidityinclinicallystablecovid19patients AT salvideepak psychiatriccomorbidityinclinicallystablecovid19patients AT gautammanaswi psychiatriccomorbidityinclinicallystablecovid19patients AT sangwanvaundhra psychiatriccomorbidityinclinicallystablecovid19patients AT tambitanushi psychiatriccomorbidityinclinicallystablecovid19patients AT kaliaanchin psychiatriccomorbidityinclinicallystablecovid19patients AT singhnishant psychiatriccomorbidityinclinicallystablecovid19patients |